Cutler Group’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-16,500
Closed -$2K 5810
2021
Q3
$2K Buy
+16,500
New +$62.7K ﹤0.01% 5045
2018
Q1
Sell
-5,600
Closed -$2K 4940
2017
Q4
$2K Buy
+5,600
New +$37.1K ﹤0.01% 4177
2017
Q1
Sell
-6,000
Closed -$4K 6893
2016
Q4
$4K Buy
+6,000
New +$42.3K ﹤0.01% 5097

Other funds holding MNOV

Cutler Group's MNOV Position: Q1 2024 in Review

Cutler Group sold out of MediciNova (MNOV) in Q1 2024, closing a stake of 2,000 shares — an estimated $3K sold.

Cutler Group first reported a position in MNOV in Q2 2016 and held it in 17 quarters. The position peaked at $39K in Q1 2021. 35 funds tracked by Wall St. Rank hold MNOV as of Q1 2024.

  • Cutler Group reported no remaining MediciNova position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 2,000 MediciNova shares in Q1 2024, an estimated $3K.
  • Cutler Group first reported a position in MediciNova in Q2 2016 and held it in 17 quarters.
  • Cutler Group's MediciNova position peaked at $39K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held MediciNova as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.